Skip to main content
. 2025 Jul 17;14(14):5077. doi: 10.3390/jcm14145077
ABMR antibody-mediated rejection
ACEis angiotensin-converting enzyme inhibitors
ACR acute T-cell-mediated rejection
AI artificial intelligence
AR acute rejection
ARBs angiotensin II receptor blockers
CAD chronic allograft dysfunction
CDSSs clinical decision support systems
CKD chronic kidney disease
CNIs calcineurin inhibitors
CNPq National Council for Scientific and Technological Development
CR chronic rejection
CV cardiovascular
ddcfDNA donor-derived cell-free DNA
DGF delayed graft function
DM diabetes mellitus
DSAs donor-specific antibodies
eGFR estimated glomerular filtration rate
HERs electronic health records
EndMT endothelial to Mesenchymal Transition
ESKD end-stage kidney disease
EV extracellular vesicles
GDF-15 growth differentiation factor-15
HF heart failure
IF/TA interstitial fibrosis/tubular atrophy
IL-6 interleukin-6
IRI ischemia–reperfusion injury
KIM-1 kidney injury molecule
KTx kidney transplantation
MCP-1 monocyte chemoattractant protein-1
MFI mean fluorescence intensity
MRA mineralocorticoid receptor antagonist
NGAL neutrophil gelatinase-associated lipocalin
Pmp per million population
RRT renal replacement therapy
SGLT2is sodium-glucose transport 2 inhibitors
suPAR soluble receptor of urokinase plasminogen activator
TLR-4 soluble Toll-like receptor 4
TNFR-1 Tumor necrosis factor receptor 1
TNFR-2 Tumor necrosis factor receptor 2
T2DM type 2 Diabetes Mellitus
USA United States of America
UACR urine albumin-to-creatinine ratio
uNAG urinary N-acetyl-β-D-glucosaminidase